Key result
Greyzone fibrosis underperforms LGE and hs-cTnT for predicting MI-free survival after acute MI.
Why the study?
Does quantification of greyzone fibrosis correlate better with MI-free survival and LVEF improvement compared to hs-cTnT and LGE in patients after acute myocardial infarction?
Cohort (n=176)
No
Does quantification of greyzone fibrosis correlate better with MI-free survival and LVEF improvement compared to hs-cTnT and LGE in patients after acute myocardial infarction?
In patients after acute myocardial infarction, greyzone fibrosis assessment by CMR is inferior to hs-cTnT and LGE for predicting MI-free survival and does not correlate with LVEF improvement.
Answers are grounded in this paper and cite their sources.
Greyzone fibrosis should not yet guide post-MI risk stratification; leaves open whether CMR tissue characterization adds value beyond LGE and hs-cTnT.
AIMS: To quantify greyzone fibrosis (GZF) in patients after acute myocardial infarction (MI) and to evaluate its correlation with MI-free survival and improvements in left ventricular ejection fraction (LVEF) compared with the established risk factors high-sensitivity cardiac troponin T (hs-cTnT) and Late Gadolinium Enhancement (LGE). METHODS AND RESULTS: The study involved 176 patients who experienced acute MI and underwent cardiac magnetic resonance (CMR) prior to hospital discharge, followed by a second CMR on average six months later. LGE was quantified in both examinations, a separate analysis of the GZF was conducted only in the follow-up CMR after resolution of the initial infarct edema. LVEF was measured in both CMR. hs-cTnT levels were assessed at hospital admission, as well as 8, 16, 24, 48 and 72 h after coronary intervention. Telephone follow-ups were conducted annually for up to 8 years. LGE measurements showed better correlation with MI-free survival (Harrell's C of 0.711 of LGE mass) compared to GZF (0.579 of GZF mass). Additionally, hs-cTnT outperformed GZF (Harrell's C of 0.645). As an univariable predictor for MI-free survival, only hs-cTnT reached significance (p < 0.05). With regard to improvements in ejection fraction, both hs-cTnT and LGE measurements showed acceptable correlation with improvement in ejection fraction (p < 0.05), while GZF measurements showed no correlation (p > 0.5). CONCLUSIONS: In CMR, the assessment of GZF demonstrated inferior p correlation compared to hs-cTnT and LGE in patients after acute MI with respect to the endpoint of MI-free survival. Furthermore, GZF showed no correlation with the improvement of LVEF.
No takes yet. Share an insight, caveat, or question.
Schmitt et al. (2024) conducted a cohort in Acute myocardial infarction (n=176). Greyzone fibrosis (GZF) vs. Late gadolinium enhancement (LGE) and high-sensitivity cardiac troponin T (hs-cTnT) was evaluated on MI-free survival (Harrell's C 0.579). In patients after acute myocardial infarction, greyzone fibrosis demonstrated inferior correlation with MI-free survival compared to late gadolinium enhancement and hs-cTnT.
Synapse has enriched 10 related papers. Consider them for comparative context: